Carbohydrates

Related people (368)

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Stewart Cole

Professor Stewart Cole is an international authority in bacterial molecular-genetics and genomics. He has made outstanding contributions in several fields including: bacterial anaerobic electron transport; genome analysis of retroviruses and papillomaviruses; antibiotic resistance mechanisms; and the molecular microbiology of toxigenic clostridia. His studies on isoniazid and multidrug resistance in Mycobacterium tuberculosis, together with his pioneering work on the pathogenicity, evolution and genomics of the tubercle and leprosy bacilli, have made him an undisputed leader in the field of mycobacterial research. The findings of his research are of direct relevance to public health and disease-control in both the developing world and the industrialised nations. He has published over 250 scientific papers and review articles, and holds many patents.

Kurt Schenk

Kim Do

Georges Wagnières

Georges Wagnières received his diploma degree (MSc) in physics from the University of Lausanne, Switzerland, in 1986. He obtained his doctorate in science (PhD) in physics (Biomedical optics) from the Swiss Federal Institute of Technology at Lausanne (EPFL) in 1992 and did a postdoctoral work in the Wellman Laboratories of Photomedicine (Harvard Medical School), Boston, USA, from 1993 to 1994. He also obtained a Master degree in Management of Technology delivered by the Ecole des Hautes Etudes Commerciales (HEC) of Lausanne University and the EPFL in 2001. Georges Wagnières manages a research group active in the fields of: - Detection of early superficial cancers by fluorescence imaging. - Characterization of early superficial cancers by high magnification narrow band imaging. - In vivo and in vitro measurement of the vascular and tissular oxygen concentration by time-resolved luminescence spectroscopy and imaging. - Preclinical and clinical study of new photosensitizers for photodynamic therapy (PDT). - Treatment of neurodegenerative conditions (Alzheimer, Parkinson's diseases) by photobiomodulation. - Preclinical and clinical photodynamic therapy of inflammatory bowel diseases and atheroscerotic plaque. - Improvement of the selective vascular extravasation of chemotherapeutic agents by PDT. - Monitoring the light dosimetry during PDT by fluorescence spectroscopy and imaging. - Monitoring laser treatments of the retina by reflectance imaging. - Light dosimetry and tissue optical spectroscopy. - Radiometry. - Development of light delivery systems for biomedical applications. Georges Wagnières is also co-founder and was chairman of one spin-off companies: - Medlight SA, founded in July 1997, which develops, produces and commercializes light distributors for photodynamic therapy. Georges Wagnières has currently authored more than 235 papers (more than 150 in international journals with review board) and is inventor of 18 patents. He supervised 12 PhD students up to now, and currently teaches biomedical optics and photomedicine in master programs and doctoral schools. In addition, he gives the course entitled "Physique Générale I" to biology first year students registered to the Biology School of the Lausanne's University. MAIN PUBLICATIONS Please visit: https://www.epfl.ch/labs/lifmet/wagnieres/publications/

Paolo Perona

Martinus Gijs

Martin A.M. Gijs received his degree in physics in 1981 from the Katholieke Universiteit Leuven, Belgium and his Ph.D. degree in physics at the same university in 1986. He joined the Philips Research Laboratories in Eindhoven, The Netherlands, in 1987. Subsequently, he has worked there on micro-and nano-fabrication processes of high critical temperature superconducting Josephson and tunnel junctions, the microfabrication of microstructures in magnetic multilayers showing the giant magnetoresistance effect, the design and realisation of miniaturised motors for hard disk applications and the design and realisation of planar transformers for miniaturised power applications. He joined EPFL in 1997. His present interests are in developing technologies for novel magnetic devices, new microfabrication technologies for microsystems fabrication in general and the development and use of microsystems technologies for microfluidic and biomedical applications in particular.

Paul Bowen

Dr. P. Bowen after gaining his BSc in Physics at Imperial College (UK), he obtained his Ph.D. in Physical Chemistry in the field of catalysis from the University of Cambridge, UK, in 1982, He then worked at the BP Research Centre, Sunbury, UK, for 4 years in applied surface sciences before moving to Switzerland and EPFL in 1987. He has been at the Powder Technology Laboratory, in the Materials Institute since its conception in 1988. He has over 190 publications and has written an undergraduate book on ceramic synthesis and processing. Education: 1976-1979 Imperial College of Science and Technology, University of London. B.Sc. Honours in Physics. 1979-1982 Department of Physical Chemistry, University of Cambridge. Certificate of Postgraduate Studies in Chemistry. Thesis: A Mössbauer Study of Some Clay Minerals and their Surfaces. Ph.D. in Physical Chemistry. Thesis: An Iron-57 and Tin-119 Mössbauer Spectroscopic Study of Some Graphite Intercalation Compounds and Carbon Supported Iron Catalysts. Professional Experience: 1983-1986 Research Scientist (Physical Chemist), New Technology Division, British Petroleum Company plc, BP Research Centre, Sunbury on Thames, Middlesex TW16 7LN, England. 1987-1988 Engineer, Ceramics Laboratory, Département des Matériaux, Ecole Polytechnique Fédérale de Lausanne, CH - 1015 Lausanne, Switzerland. 1988-2008 Research Associate/lecturer, Powder Technology Laboratory (Present) Institute des Matériaux, Ecole Polytechnique Fédérale de Lausanne, CH - 1015 Lausanne, Switzerland. 1988- 2015 Maitre DEnsiegnement et Recherche (Lecturer & Researcher), Powder Technology Laboratory, Institute des Matériaux, Ecole Polytechnique Fédérale de Lausanne,CH - 1015 Lausanne, Switzerland 2015 – present Adjunct Professor (Professeur Titulaire), Powder Technology Laboratory (LTP), Materials Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH - 1015 Lausanne, Switzerland

Maurizio Molinari

Athanasios Nenes

Gerardo Turcatti

Senior scientific level (R&D) with extensive experience in the management of multidisciplinary technological projects. Prof. Gerardo Turcatti, directs the academic technological platform, Biomolecular Screening Facility (BSF) at the EPFL he created in 2006. In the framework of the NCCR-Chemical Biology, he is project leader of the program ACCESS (An Academic Chemical Screening Platform for Switzerland). Previously he co-founded and acted as CTO of Manteia S.A., a Swiss-based company that developed high throughput DNA sequencing technologies currently owned by Illumina and used in the ‘Next Generation Sequencing’ instruments. Prior to this experience, Prof. Turcatti had a long multidisciplinary career in R&D divisions of Biotechnology and Pharmaceutical companies with extensive expertise in several Chemical Biology-related disciplines such as Drug Screening, Chemical Biology, Bio-analytical Chemistry, DNA and Protein Chemistry. Prof. Turcatti earned his Master in Chemical Engineering at the University of Geneva and his PhD in Chemistry and Biochemistry from the EPFL where he received the award for the best doctoral thesis of the year.